Veradigm to participate in two upcoming investor conferences. MWN-AI** Summary. Veradigm(R)(OTCMKTS: MDRX), a prominent provider of clinical and revenue cycle solutions tailored for independent medical practices, has announced its participation in two key investor conferences scheduled for September 2026. The company's executives, including CEO Don Trigg and CFO Christian Greyenbuhl, are set to engage with investors at these notable events. The first conference, the Jefferies Healthcare Services and Technology Conference, will take place in Nashville on September 15, 2026. During this event, Trigg and Greyenbuhl will conduct one-on-one meetings with investors and will also partake in a fireside chat at 4:10 PM CT. For those unable to attend in person, a live webcast of the discussion will be accessible on Veradigm's investor relations website, providing wider access to their insights and updates. The following day, September 16, 2026, the duo will represent Veradigm at the Deutsche Bank Healthcare Summit in New York. Similar to the prior event, they will engage in one-on-one meetings, where investors can discuss the company's latest developments. Interested parties are encouraged to reach out to their Deutsche Bank representatives for additional details regarding participation. Veradigm has earned a reputation for facilitating improved clinical outcomes and financial performance through its innovative AI-driven solutions, which enhance the efficiency of over 20,000 provider practices. Moreover, Veradigm's technology fosters collaboration between healthcare providers and health plans, aiming to streamline processes, address care gaps, and contribute to a more cost-effective healthcare system. MWN-AI** Analysis. Veradigm(R)(OTCMKTS: MDRX), a prominent player in the healthcare technology space, is gearing up for two significant investor conferences this September: the Jefferies Healthcare Services and Technology Conference and the Deutsche Bank 2026 Healthcare Summit. This presents a unique opportunity for investors to gain insights into the company's advancements and strategic direction. Veradigm has established itself as a leader in providing clinical and revenue cycle solutions tailored for independent practices. The company's focus on leveraging AI-driven data to connect over 20,000 provider practices with health plans and biopharma partners is key to eliminating inefficiencies and improving patient outcomes. In an era where healthcare costs continually rise, Veradigm's solutions position it well to capitalize on the need for more affordable care. Participating in these conferences allows Veradigm's leadership, including CEO Don Trigg and CFO Christian Greyenbuhl, to engage directly with investors, presenting growth strategies and answering critical questions regarding financial performance and market positioning. The webcast of the fireside chat at the Jefferies Conference is particularly noteworthy, as it provides broader access to insights that could influence market sentiment. Investors should keep an eye on the discussions surrounding Veradigm's recent innovations and potential partnerships that may arise from these conferences. The capability to improve operational efficiencies and patient care is a compelling narrative for institutional investors looking for sustainable growth within the healthcare technology sector. With the ongoing evolution in healthcare demands, Veradigm's proactive stance and their participation in high-profile investor events symbolize confidence in their future trajectory. Investors considering a stake in Veradigm should monitor developments closely, especially following these conferences, for any shifts in strategic collaborations or product enhancements that could bolster market performance. **MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release. August 17, 2026 08:01:00 am Veradigm(R)(OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management will be participating in the following investor conferences in September. 2026 Jefferies Healthcare Services and Technology Conference (Nashville, September 15, 2026) Don Trigg, Chief Executive Officer, and Christian Greyenbuhl, Chief Financial Officer, will hold one-on-one meetings and participate in a fireside chat on Tuesday, September 15 [th] at 4:10PM CT. A live webcast of the fireside chat will be available at the Veradigm investor relations website. Deutsche Bank 2026 Healthcare Summit (New York, September 16, 2026) Don Trigg, Chief Executive Officer, and Christian Greyenbuhl, Chief Financial Officer, will participate in one-on-one meetings on Wednesday, September 16 [th]. Investors should contact their Deutsche Bank representative for additional information. About Veradigm(R) Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Its AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system. FAQ**. How does Veradigm Inc. MDRX plan to leverage AI technology to enhance its clinical and revenue cycle solutions for independent practices in the upcoming investor conferences? Veradigm Inc. (MDRX) plans to leverage AI technology to enhance its clinical and revenue cycle solutions by showcasing innovative data analytics and automation capabilities at upcoming investor conferences, aimed at improving operational efficiency for independent practices. What specific goals does Veradigm Inc. MDRX aim to achieve during the 20jefferies Healthcare Services and Technology Conference and the Deutsche Bank 20healthcare Summit? Veradigm Inc. (MDRX) aims to showcase its innovative healthcare technology solutions, highlight growth strategies, and engage with investors and industry leaders to strengthen partnerships and drive its market position during the 2026 conferences. Can you provide insights into the financial performance of Veradigm Inc. MDRX and how it has improved outcomes for over 20,000 provider practices? Veradigm Inc. (MDRX) has demonstrated strong financial performance through steady revenue growth, driven by its innovative healthcare technology solutions that enhance clinical workflows and improve patient outcomes for over 20,000 provider practices. What feedback does Veradigm Inc. MDRX anticipate from investors during the one-on-one meetings at the September conferences, particularly regarding its solutions for eliminating healthcare inefficiencies? Veradigm Inc. (MDRX) anticipates investor feedback during the September conferences to focus on the effectiveness, scalability, and potential impact of its solutions for reducing healthcare inefficiencies and improving overall operational workflows within the industry. **MWN-AI FAQ is based on asking OpenAI questions about Veradigm Inc. (OTC: MDRX).

Aptarro names Paul Wiley chief growth officer to expand reimbursement intelligence platform. July 15, 2026 Paul Wiley Aptarro has appointed healthcare technology executive Paul Wiley as chief growth officer, adding a commercial leader to accelerate adoption of its reimbursement intelligence platform as healthcare providers seek to reduce claim denials and improve revenue cycle performance. Wiley will oversee Aptarro's commercial organization, including sales, partnerships and customer success, as the Florida-based company expands its portfolio of denial prevention and reimbursement intelligence products. The appointment supports the company's strategy of scaling its go-to-market operations while deepening relationships with healthcare providers, revenue cycle management firms and technology partners. The move comes as healthcare organizations continue to face growing administrative costs associated with claim denials and reimbursement complexity. Aptarro's platform is designed to analyze claims and remittance data, using information from processed claims and denials to generate intelligence that helps providers identify reimbursement risks before claims are submitted. Chief Executive Officer Jeff Diamond said the company is investing in leadership to support the next stage of its growth. "As reimbursement continues to grow more dynamic, healthcare organizations need technology that evolves alongside it. We're building the leadership team to support that mission," Diamond said. "Paul's experience will be instrumental as we continue expanding our platform and defining the future of reimbursement intelligence." Wiley brings more than 20 years of leadership experience across healthcare technology, enterprise software, artificial intelligence and travel technology. Most recently, he served as chief commercial officer at Avodah. Before that, he founded Opargo, an AI-powered healthcare scheduling company that applied predictive revenue management techniques developed in the airline industry to healthcare. Opargo was later acquired by Veradigm. Throughout his career, Wiley has held executive leadership positions focused on commercial strategy, product development and business growth, experience Aptarro expects to leverage as it expands both direct customer relationships and strategic partnerships across the healthcare ecosystem. "I'm excited to join Aptarro at such a pivotal point in its journey," Wiley said. "The industry has spent decades managing denials after the fact. Aptarro has the reimbursement expertise, the data network and the vision to prevent denials in the first place, and deliver that intelligence wherever providers and their technology partners need it." The company said Wiley's appointment aligns with its long-term strategy of expanding beyond traditional revenue cycle software into a reimbursement intelligence platform whose data and analytics can be integrated into healthcare workflows and third-party technology solutions. Aptarro is also positioning its platform to support emerging AI-driven and automated revenue cycle applications that rely on accurate reimbursement data and predictive insights. Backed by TA Associates, Aptarro develops healthcare technology for providers, revenue cycle management companies and technology partners. Its platform combines claims and remittance expertise with a growing data network designed to help healthcare organizations reduce denials, accelerate reimbursement and improve revenue cycle performance through data-driven operational intelligence.